Form 4: LEVI Director to Acquire Shares via DERs

Sentiment:

Insider Transaction Report


Levi Strauss & Co. Director David S. Marberger is scheduled to acquire 102 shares of Class A Common Stock through dividend equivalent rights on August 8, 2025.

Summary

  • David S. Marberger, a Director of Levi Strauss & Co. (LEVI), is scheduled to acquire 102 shares of Class A Common Stock.
  • This acquisition is set to occur on August 8, 2025.
  • The shares will be acquired at a price of $0.00, indicating they are part of a compensation or dividend equivalent plan.
  • The acquisition represents Dividend Equivalent Rights (DERs), which are contingent rights to receive one share of Class A Common Stock upon settlement.
  • Following this future transaction, David S. Marberger will directly beneficially own 22,645 shares of Class A Common Stock.
  • The DERs vest and are delivered consistent with the underlying awards, with unvested awards vesting 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the underlying award's grant date.
  • Certain underlying awards are fully vested but subject to a deferred delivery feature, which also applies to the related DERs.

Sentiment

Score: 7

Explanation: The scheduled acquisition of shares by a director, even as part of compensation, generally signals continued confidence in the company's future and aligns management interests with shareholders.

Positives

  • Director David S. Marberger is scheduled to increase his direct beneficial ownership in Levi Strauss & Co. by 102 shares.
  • The future acquisition of shares through Dividend Equivalent Rights (DERs) aligns the director's interests with long-term shareholder value.

Future Outlook

The filing indicates a future transaction where Director David S. Marberger will acquire 102 shares on August 8, 2025, as part of Dividend Equivalent Rights. These DERs, along with related unvested awards, are set to vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the underlying award's grant date. Certain fully vested underlying awards and their related DERs are subject to a deferred delivery feature.

Industry Context

This filing details a routine insider transaction related to director compensation, which is a common practice across various industries to align executive and director interests with shareholder value. It does not provide insights into broader industry trends or competitive dynamics.

Related Party Transactions

  • Scheduled acquisition of 102 shares of Class A Common Stock by Director David S. Marberger through Dividend Equivalent Rights (DERs) from Levi Strauss & Co.

Stakeholder Impact

  • Shareholders: Increased alignment of director's interests with shareholders due to increased stock ownership.

Next Steps

  • Vesting and delivery of Dividend Equivalent Rights (DERs) consistent with underlying awards.
  • Unvested awards and related DERs will vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the underlying award's grant date.

Key Dates

DateDescription
08/08/2025Scheduled date for the acquisition of 102 Class A Common Stock shares by Director David S. Marberger.
08/12/2025Date the Form 4 was signed and filed.

Recommendation

hold

This Form 4 filing details a routine acquisition of shares by a director as part of their compensation package, specifically through Dividend Equivalent Rights. While it indicates continued alignment of the director's interests with shareholders, the transaction size (102 shares) and nature (compensation-related) are not significant enough to warrant a change in investment recommendation. It is a standard corporate governance event rather than a material operational or financial development.

Keywords

Levi Strauss, LEVI, Insider Trading, Form 4, Director, Stock Acquisition, Dividend Equivalent Rights, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.